Literature DB >> 10566709

A survey of gastroenterologists' perceptions and practices related to Helicobacter pylori infection.

V K Sharma1, R Vasudeva, C W Howden.   

Abstract

OBJECTIVE: The aim of this study was to assess the current practice of gastroenterologists in the United States concerning Helicobacter pylori (H. pylori) infection.
METHODS: We mailed a structured questionnaire to 1000 gastroenterologists chosen at random from a national database. We asked about personal and practice demographics and practices relating to testing for, and treating, H. pylori infection.
RESULTS: A total of 922 questionnaires were delivered, from which we received 286 responses (31%). Respondents used many different tests for H. pylori infection, but only 10% each had used either the 13C- or 14C-urea breath test. Testing for H. pylori infection was usually for appropriate reasons, although 21% indicated that they might not treat a patient with a positive test result. Different multiple treatment regimens were used; the most frequent were combinations of a proton pump inhibitor, clarithromycin, and either amoxicillin or metronidazole. Estimates of the prevalence of antibiotic resistance were highly variable and often inaccurate. Most respondents would not check asymptomatic individuals for the infection; however, in the absence of symptoms, 38% would personally undergo testing and treatment if positive.
CONCLUSIONS: Gastroenterologists usually test for H. pylori infection in appropriate conditions, but may not always treat the infection based on a positive test result. Most use efficacious regimens to treat the infection although many have inaccurate information on resistance rates, which may adversely influence prescribing. Many would have testing and, if positive, treatment in the absence of symptoms or a specific diagnosis, but do not recommend this for their patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10566709     DOI: 10.1111/j.1572-0241.1999.01512.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  3 in total

1.  Utility of the Nonabsorbed (<0.4%) Antibiotic Rifaximin in Gastroenterology and Hepatology.

Authors:  Chinyu G Su; Faten Aberra; Gary R Lichtenstein
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-03

2.  Survey of general practitioners' knowledge about Helicobacter pylori infection.

Authors:  Sevgi Canbaz; Ahmet Tevfik Sunter; Yildiz Peksen; Hakan Leblebicioglu
Journal:  BMC Gastroenterol       Date:  2005-01-26       Impact factor: 3.067

3.  Physicians' adherence to management guidelines for H. pylori infection and gastroesophageal reflux disease: a cross-sectional study.

Authors:  Wasef Na'amnih; Amir Ben Tov; Amna Bdair-Amsha; Shlomi Cohen; Judith Tsamir; Gabriel Chodick; Khitam Muhsen
Journal:  Isr J Health Policy Res       Date:  2020-06-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.